Biofrontera Inc. (BFRIW)
0.08
0.02 (37.93%)
At close: Mar 04, 2025, 10:12 AM
Biofrontera Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 1.34M | 17.21M | 24.55M | 8.08M | 7.3M |
| Short-Term Investments | 78K | 10.55M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 2.81M | 2.81M | n/a | n/a |
| Other Long-Term Assets | 482K | 3.13M | 3.08M | 323K | 494K |
| Receivables | 5.16M | 7.41M | 3.78M | 3.29M | 4.79M |
| Inventory | 10.91M | 7.17M | 4.46M | 7.09M | 10.48M |
| Other Current Assets | 5.58M | 810K | 13.63M | 1.12M | 900K |
| Total Current Assets | 23.07M | 43.14M | 46.42M | 19.58M | 23.47M |
| Property-Plant & Equipment | 1.75M | 1.58M | 267K | 370K | 503K |
| Goodwill & Intangibles | 2.63M | 3.03M | 3.45M | 3.87M | 4.29M |
| Total Long-Term Assets | 4.86M | 7.74M | 6.8M | 4.56M | 5.28M |
| Total Assets | 27.93M | 50.88M | 53.22M | 24.14M | 28.75M |
| Account Payables | 8.91M | 1.28M | 658K | 1.51M | 7.21M |
| Deferred Revenue | n/a | 6.94M | 3.24M | n/a | n/a |
| Short-Term Debt | 4.59M | 996K | n/a | n/a | n/a |
| Other Current Liabilities | 4.59M | 11.68M | 9.94M | 2.91M | 4.53M |
| Total Current Liabilities | 18.09M | 20.89M | 13.84M | 4.42M | 11.74M |
| Long-Term Debt | 804K | 848K | n/a | n/a | 38.2M |
| Other Long-Term Liabilities | 4.25M | 2.86M | 18.5M | 62K | 58K |
| Total Long-Term Liabilities | 5.05M | 6.11M | 28.05M | 13.89M | 47.19M |
| Total Liabilities | 23.14M | 27M | 41.88M | 18.31M | 58.93M |
| Total Debt | 5.4M | 1.35M | n/a | n/a | 38.2M |
| Common Stock | 2K | 27K | 17K | 8K | n/a |
| Retained Earnings | -99.65M | -79.52M | -78.88M | -41.17M | -30.18M |
| Comprehensive Income | n/a | n/a | 0.00 | n/a | n/a |
| Shareholders Equity | 4.79M | 23.88M | 11.34M | 5.83M | -30.18M |
| Total Investments | 78K | 10.55M | 2.81M | n/a | n/a |